Published in RNA on October 01, 2005
A rapid high-throughput method for the detection and quantification of RNA editing based on high-resolution melting of amplicons. Nucleic Acids Res (2007) 1.62
Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res (2010) 1.00
High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol (2010) 0.93
Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Physiol Behav (2009) 0.89
Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders. Neurobiol Dis (2011) 0.85
Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes. J Psychiatry Neurosci (2011) 0.84
A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia. Mol Brain (2014) 0.84
Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 transgenic mice. Genes Brain Behav (2011) 0.81
Quantification of adenosine-to-inosine editing of microRNAs using a conventional method. Nat Protoc (2012) 0.79
An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. J Neurosci Methods (2009) 0.78
RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation. J Neurochem (2009) 0.77
Abundant and selective RNA-editing events in the medicinal mushroom Ganoderma lucidum. Genetics (2014) 0.76
A sequencing method based on real-time pyrophosphate. Science (1998) 21.21
RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem (2001) 9.66
Advanced sequencing technologies: methods and goals. Nat Rev Genet (2004) 9.31
Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature (1997) 7.92
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature (1995) 4.36
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron (2002) 3.06
Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat (2002) 2.36
A-to-I RNA editing: recent news and residual mysteries. J Biol Chem (2002) 2.20
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem (1999) 2.10
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Genetic variation analyses by Pyrosequencing. Mutat Res (2005) 1.86
The RNA world meets behavior: A-->I pre-mRNA editing in animals. Trends Genet (2001) 1.72
Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem (2000) 1.64
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology (2001) 1.62
How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci (2005) 1.57
A-to-I editing: new and old sites, functions and speculations. Neuron (2002) 1.47
RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry (2001) 1.45
Pyrosequencing for SNP genotyping. Methods Mol Biol (2003) 1.37
Pyrosequencing: a tool for DNA sequencing analysis. Methods Mol Biol (2004) 1.32
RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett (2003) 1.26
Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem (1999) 1.24
Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology (1999) 1.23
Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry (2001) 1.11
Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res Mol Brain Res (2004) 1.11
A multi-enzyme model for Pyrosequencing. Nucleic Acids Res (2004) 1.04
Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol Psychiatry (2004) 1.04
Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res (2005) 1.01
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet (1998) 1.00
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem (2003) 0.96
Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology (Berl) (2000) 0.89
Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis. Biol Psychiatry (2003) 0.86
Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder. Am J Med Genet (1997) 0.84
Serotonin 2C receptor gene Cys23Ser polymorphism: a candidate genetic risk factor of migraine with aura in Japanese population. Acta Neurol Scand (2004) 0.82
Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder. Neurosci Lett (2001) 0.81
Effects of cocaine and reserpine administration on RNA editing of rat 5-HT2C receptor estimated by primer extension combined with denaturing high-performance liquid chromatography. Pharmacogenomics J (2002) 0.80
Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02
Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell (2009) 3.45
Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature (2003) 2.97
Infant calming responses during maternal carrying in humans and mice. Curr Biol (2013) 2.35
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci (2012) 1.80
Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet (2006) 1.78
Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: a relation with post-traumatic stress disorder. Neurosci Res (2002) 1.73
Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res (2011) 1.61
DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci (2005) 1.49
Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet (2003) 1.46
Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res (2007) 1.30
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology (2008) 1.29
RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett (2003) 1.26
Detection of chromosomal structural alterations in single cells by SNP arrays: a systematic survey of amplification bias and optimized workflow. PLoS One (2007) 1.25
Genetic variation of melatonin productivity in laboratory mice under domestication. Proc Natl Acad Sci U S A (2010) 1.24
Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry (2007) 1.22
A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry (2005) 1.20
Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res (2010) 1.14
The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem (2007) 1.14
A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry (2005) 1.11
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 1.11
DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet (2013) 1.08
Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci (2004) 1.08
Human brain structural change related to acute single exposure to sarin. Ann Neurol (2007) 1.07
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet (2006) 1.07
Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist (2006) 1.05
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res (2002) 1.05
Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet (2012) 1.04
Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet (2004) 1.04
Genome-wide association study of schizophrenia in Japanese population. PLoS One (2011) 1.02
Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines. Epigenetics (2011) 1.02
Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res (2005) 1.01
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry (2005) 1.01
Epigenetics in mood disorders. Environ Health Prev Med (2007) 1.00
Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res (2004) 0.99
Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol (2009) 0.99
Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy. Neuroimage (2005) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. Genomics (2004) 0.98
XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. J Neurochem (2006) 0.97
DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res (2013) 0.97
ERK-FosB signaling in dorsal MPOA neurons plays a major role in the initiation of parental behavior in mice. Mol Cell Neurosci (2007) 0.96
A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry (2012) 0.96
Epigenetic profiling in schizophrenia and major mental disorders. Neuropsychobiology (2009) 0.95
Variant GADL1 and response to lithium in bipolar I disorder. N Engl J Med (2014) 0.95
Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochem Biophys Res Commun (2005) 0.95
Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol (2008) 0.94
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am J Med Genet B Neuropsychiatr Genet (2006) 0.94
Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res (2006) 0.92
Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Neuropsychopharmacology (2008) 0.92
Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. Neurosci Res (2008) 0.91
Up-regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
Evaluation of whole genome amplification methods using postmortem brain samples. J Neurosci Methods (2007) 0.91
Functional, anatomical, and neurochemical differentiation of medial preoptic area subregions in relation to maternal behavior in the mouse. J Comp Neurol (2013) 0.89
Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum Mol Genet (2013) 0.89
Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study. Psychiatry Clin Neurosci (2004) 0.89
Support for relationship between serum cholinesterase and post-traumatic stress disorder; 5-year follow-ups of victims of the Tokyo subway sarin poisoning. Neurosci Res (2005) 0.89
Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res (2005) 0.89
Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol (2013) 0.89
Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet (2009) 0.88
Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS One (2009) 0.88
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One (2013) 0.88
Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol (2005) 0.87
Association study between the TNXB locus and schizophrenia in a Japanese population. Am J Med Genet B Neuropsychiatr Genet (2007) 0.87
Mitochondrial DNA sequence analysis of patients with 'atypical psychosis'. Psychiatry Clin Neurosci (2005) 0.87
Cerebrovascular response to cognitive tasks in patients with schizophrenia measured by near-infrared spectroscopy. Schizophr Bull (2004) 0.87
No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr Res (2006) 0.87
Activation of the prefrontal cortex to trauma-related stimuli measured by near-infrared spectroscopy in posttraumatic stress disorder due to terrorism. Psychophysiology (2003) 0.87
Association analysis of HSP90B1 with bipolar disorder. J Hum Genet (2007) 0.86
Hypoactivation of the prefrontal cortex during verbal fluency test in PTSD: a near-infrared spectroscopy study. Psychiatry Res (2003) 0.86
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology (2007) 0.86
Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord (2005) 0.86
Exome sequencing identifies a novel missense variant in RRM2B associated with autosomal recessive progressive external ophthalmoplegia. Genome Biol (2011) 0.86
Genome-wide DNA methylation and gene expression analyses of monozygotic twins discordant for intelligence levels. PLoS One (2012) 0.86
A systematic evaluation of whole genome amplification of bisulfite-modified DNA. Clin Epigenetics (2012) 0.85
No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry (2004) 0.85
Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin Neurosci (2004) 0.85
Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis. Psychiatry Res (2010) 0.85
FosB null mutant mice show enhanced methamphetamine neurotoxicity: potential involvement of FosB in intracellular feedback signaling and astroglial function. Neuropsychopharmacology (2009) 0.85
Abnormal Ca2+ dynamics in transgenic mice with neuron-specific mitochondrial DNA defects. J Neurosci (2006) 0.85